NCT05704049
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05704049
Title A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (IZALCO)
Acronym IZALCO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: senior | adult
Covered Countries GRC | CZE | BRA | AUS

Facility Status City State Zip Country Details
Investigational Site Number : 0360002 Wollongong New South Wales 2500 Australia Details
Investigational Site Number : 0360001 Melbourne Victoria 3065 Australia Details
Hospital Mae de Deus Site Number : 0760002 Porto Alegre Rio Grande do Sul 90880-480 Brazil Details
Clinica São Germano- Site Number : 0760003 São Paulo 04537-080 Brazil Details
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760001 São Paulo 05403-000 Brazil Details
Investigational Site Number : 1560006 Changsha 410013 China Details
Investigational Site Number : 1560002 Guangzhou 510060 China Details
Investigational Site Number : 1560005 Nanchang 330006 China Details
Investigational Site Number : 1560004 Shenyang 110004 China Details
Investigational Site Number : 1560001 Tianjin 300020 China Details
Investigational Site Number : 1560007 Tianjin 300060 China Details
Investigational Site Number : 1560003 Wuhan 430030 China Details
Investigational Site Number : 2030002 Brno 625 00 Czechia Details
Investigational Site Number : 2030004 Olomouc 779 00 Czechia Details
Investigational Site Number : 2030003 Ostrava 708 52 Czechia Details
Investigational Site Number : 2030001 Prague 128 08 Czechia Details
Investigational Site Number : 3000001 Athens 106 76 Greece Details
Investigational Site Number : 3000002 Athens 115 28 Greece Details
Investigational Site Number : 3920001 Kashiwa Chiba 277-8577 Japan Details
Investigational Site Number : 3920002 Okayama 701-1192 Japan Details
Investigational Site Number : 6200001 Braga 4710-243 Portugal Details
Investigational Site Number : 6200004 Lisbon 1400-038 Portugal Details
Investigational Site Number : 6200005 Lisbon 1649-035 Portugal Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field